13 Dec 2024 16:49
PT Indofarma announced that it will sell its assets worth around IDR 312.94 billion consisting of land and buildings located in 10 provinces in Indonesia.
13 Dec 2024 09:47
PT Indofarma Tbk (INAF) is reportedly planning to divest over 50% of company assets, according to the report received by IDNFinancials from Indonesia Stock Exchange (IDX) last Thursday (12/12).
03 Sep 2024 09:07
PT Indofarma Tbk (INAF), a state-owned medicine and medical device manufacturer, is said to sell off its remaining assets to pay arrears to its own employees.
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
16 Jan 2024 10:27
The shareholders of PT Indofarma Tbk (INAF) has agreed upon the guarantee of over 50% of net assets of the company as a collateral for the company’s obligation.
31 May 2023 17:29
The proposal of PT Indofarma (Persero) Tbk (INAF) to request for a shareholder loan worth IDR 157 billion had been approved by independent shareholders during today’s (31/5) Annual General Shareholders Meeting.
30 May 2023 08:11
PT Indofarma (Persero) Tbk (INAF) obtains a loan from PT Bio Farma (Persero), its controlling shareholder, worth IDR 157 billion for restructuring.
19 Apr 2023 05:40
PT Bio Farma (Persero), the parent of a pharmaceutical holding company owned by the Government of Indonesia, will distribute a loan facility worth IDR 157 billion to support the restructuring plan of PT Indofarma Tbk (INAF).
03 Apr 2023 06:01
The revenue of PT Indofarma Tbk (INAF), a pharmaceutical company, was seen declining 60.56% year-on-year (yoy).
